Intuitive Surgical (ISRG) Currently in 26 Lawsuits Over da Vinci Procedures

Go back to Intuitive Surgical (ISRG) Currently in 26 Lawsuits Over da Vinci Procedures

Barrington Research Adds Intuitive Surgical (ISRG) to 'Best Ideas List'

April 19, 2013 1:11 PM EDT

Earlier, Barrington Research reiterated its Outperform rating on Intuitive Surgical (NASDAQ: ISRG) and added the stock to its 'Best Ideas List' following Q1 results after the close. The price target of $650 was also maintained.

"We view ISRG as best in-breed and liquid enough that everyone can invest... More

Weakness in Intuitive Surgical (ISRG) is A Buying Opportunity - Goldman Sachs

April 19, 2013 12:30 PM EDT

Goldman Sachs lowered its price target on Intuitive Surgical (NASDAQ: ISRG) from $712 to $684 but maintained a Buy rating following what is called "solid" Q1 results. The firm sees weakness as a buying opportunity.

While revenue exceeded expectations, procedure growth fell short and... More

Intuitive Surgical, Inc. (ISRG) Tops Q1 EPS by 56c, Sales Rise 23%

April 18, 2013 4:06 PM EDT

(Updated - April 18, 2013 4:37 PM EDT)

Intuitive Surgical, Inc. (NASDAQ: ISRG) reported Q1 EPS of $4.56, $0.56 better than the analyst estimate of $4.00. Revenue for the quarter rose 23% to $611 million versus the consensus estimate of $583.59 million.

"We are pleased with our first quarter revenue and earnings growth. Despite a concerted effort by vocal... More